日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Topography of Slowed Dark Adaptation in Pseudoxanthoma Elasticum: PROPXE Study Report 1

假性黄色瘤暗适应减缓的地形学:PROPXE 研究报告 1

Pfau, Kristina; Ansari, Georg; Michels, Stephan; Dysli, Chantal; Liakopoulos, Sandra; Burghaus-Zhang, Jana; Al-Sheikh, Mayss; Garweg, Justus G; Quinodoz, Mathieu; Kaminska, Karolina; Cancellieri, Francesca; Rivolta, Carlo; Terry, Sharon F; Feltgen, Nicolas; Pfau, Maximilian

Comparison of treatment routine using aflibercept: Strict vs. relaxed retreatment regimen (TOLERANT study)-A non-inferiority, randomized controlled trial

使用阿柏西普治疗方案的比较:严格与宽松的再治疗方案(TOLERANT 研究)——一项非劣效性随机对照试验

Jaggi, Damian; Berger, Lieselotte E; Zweifel, Sandrine; Becker, Matthias D; Michels, Stephan; Stalder, Odile; Lincke, Joel-Benjamin; Habra, Oussama; Wolf, Sebastian; Zinkernagel, Martin S

Aflibercept high-dose (8mg) related intraocular inflammation (IOI) - a case series

阿柏西普高剂量(8mg)相关眼内炎症(IOI)——病例系列

Hoffmann, Laura; Michels, Stephan; Eandi, Chiara; Karam, Muntadher Al; Figueiredo, Eva C de Oliveira; Hatz, Katja

Epiretinal membrane surgery outcome in eyes with abnormalities of the central bouquet

中央束状结构异常眼视网膜前膜手术的预后

Brinkmann, Max P; Michels, Stephan; Brinkmann, Carolin; Rommel, Felix; Ranjbar, Mahdy; Graf Johansen, Nicole; Becker, Matthias

Two-year outcomes of intravitreal aflibercept in a Swiss routine treat and extend regimen for patients with neovascular age-related macular degeneration

瑞士一项针对新生血管性年龄相关性黄斑变性患者的常规治疗和延长方案中,玻璃体内注射阿柏西普的两年疗效

Ebneter, Andreas; Michels, Stephan; Pruente, Christian; Imesch, Pascal; Eilenberger, Felix; Oesch, Susanne; Thomet-Hunziker, Isabelle P; Hatz, Katja

Photodynamic therapy in combination with intravitreal ziv-aflibercept and aflibercept injection in patients with chronic or repeatedly recurrent acute central serous chorioretinopathy: a single-center retrospective study

光动力疗法联合玻璃体内注射ziv-aflibercept和aflibercept治疗慢性或反复复发性急性中心性浆液性脉络膜视网膜病变:一项单中心回顾性研究

Doepfner, Juliane Maria; Michels, Stephan; Graf, Nicole; Becker, Matthias Dieter; Freiberg, Florentina Joyce

Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept

比较雷珠单抗和阿柏西普治疗新生血管性年龄相关性黄斑变性患者视网膜色素上皮丢失进展速度。

Wons, Juliana; Wirth, Magdalena A; Graf, Nicole; Becker, Matthias D; Michels, Stephan

SAVE-AMD: Safety of VEGF Inhibitors in Age-Related Macular Degeneration.

SAVE-AMD:VEGF抑制剂在年龄相关性黄斑变性中的安全性

Enseleit Frank, Michels Stephan, Sudano Isabella, Stahel Marc, Zweifel Sandrine, Schlager Oliver, Becker Matthias, Winnik Stephan, Nägele Matthias, Flammer Andreas J, Neidhart Michel, Graf Nicole, Matter Christian M, Seifert Burkhardt, Lüscher Thomas F, Ruschitzka Frank

Aflibercept in branch retinal vein occlusion as second line therapy: clinical outcome 12 months after changing treatment from bevacizumab/ranibizumab-a pilot study

阿柏西普作为分支视网膜静脉阻塞二线治疗:从贝伐珠单抗/雷珠单抗换用阿柏西普治疗12个月后的临床结果——一项试点研究

Wirth, Magdalena A; Becker, Matthias D; Graf, Nicole; Michels, Stephan

Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy

糖尿病视网膜病变中心凹无血管区的光学相干断层扫描血管造影

Freiberg, Florentina J; Pfau, Maximilian; Wons, Juliana; Wirth, Magdalena A; Becker, Matthias D; Michels, Stephan